CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,303,568 | +20.7% | 341,478 | -1.4% | 0.08% | +10.4% |
| Q2 2023 | $7,708,980 | +2.0% | 346,471 | -0.7% | 0.08% | +11.6% |
| Q1 2023 | $7,555,225 | +1.1% | 348,810 | -5.2% | 0.07% | -83.9% |
| Q4 2022 | $7,471,379 | -22.7% | 367,867 | -2.4% | 0.43% | +102.8% |
| Q3 2022 | $9,663,000 | +5.8% | 376,855 | -1.9% | 0.21% | +16.6% |
| Q2 2022 | $9,137,000 | +4.0% | 384,231 | -1.5% | 0.18% | +25.7% |
| Q1 2022 | $8,783,000 | – | 389,999 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |